<DOC>
	<DOCNO>NCT02661646</DOCNO>
	<brief_summary>Assessment QOL symptom change primary secondary , unilateral bilateral low extremity patient use advanced pneumatic compression system .</brief_summary>
	<brief_title>Quality Life Changes Lower Extremity Lymphedema Patients Using Advanced PCD</brief_title>
	<detailed_description>Multi-centered , single arm , observational clinical trial prospective cohort estimate 300 participant primary secondary , unilateral bilateral , low extremity lymphedema . All participant receive intermittent pneumatic compression treatment 52 week . Quality life symptom assess pre- post - intermittent pneumatic compression treatment 12 , 24 52 week .</detailed_description>
	<mesh_term>Lymphedema</mesh_term>
	<criteria>Age 18 old Diagnosis primary secondary , unilateral bilateral low extremity lymphedema Ability willingness participate aspect study ability provide inform consent . Must prescription study device Diagnosis active recurrent cancer , less 3 month time initial evaluation completion chemotherapy , radiation therapy primary surgery treatment cancer . Diagnosis acute infection . The source infection must treat 2 week prior admittance study . Acute thrombophlebitis ( last 2 month ) Pulmonary embolism deep vein thrombosis within previous 6 month Pulmonary edema Class IV congestive heart failure Patients poorly control asthma Previous use study pneumatic compression device Pregnant woman woman childbearing potential contraception Any condition increase venous lymphatic return undesirable Currently participate another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Chronic Swelling</keyword>
	<keyword>Leg Lymphedema</keyword>
	<keyword>Primary Lymphedema</keyword>
	<keyword>Secondary Lymphedema</keyword>
</DOC>